Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 309

1.

Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion.

Schwartz LM, Woloshin S, Lu Z, Ross KM, Tessema FA, Peter D, Kesselheim AS.

Circ Cardiovasc Qual Outcomes. 2019 Nov;12(11):e006073. doi: 10.1161/CIRCOUTCOMES.119.006073. Epub 2019 Nov 11.

PMID:
31707825
2.

Giardia Infection and Trypanosoma Cruzi Exposure in Dogs in the Bosaw√°s Biosphere Reserve, Nicaragua.

Roegner AF, Daniels ME, Smith WA, Gottdenker N, Schwartz LM, Liu J, Campbell A, Fiorello CV.

Ecohealth. 2019 Sep;16(3):512-522. doi: 10.1007/s10393-019-01434-2. Epub 2019 Aug 14.

PMID:
31414319
3.

Impact of Rotavirus Vaccine Introduction in Children Less Than 2 Years of Age Presenting for Medical Care With Diarrhea in Rural Matlab, Bangladesh.

Schwartz LM, Zaman K, Yunus M, Basunia AH, Faruque ASG, Ahmed T, Rahman M, Sugimoto JD, Halloran ME, Rowhani-Rahbar A, Neuzil KM, Victor JC.

Clin Infect Dis. 2019 Nov 27;69(12):2059-2070. doi: 10.1093/cid/ciz133.

4.

Skeletal Muscles Do Not Undergo Apoptosis During Either Atrophy or Programmed Cell Death-Revisiting the Myonuclear Domain Hypothesis.

Schwartz LM.

Front Physiol. 2019 Jan 25;9:1887. doi: 10.3389/fphys.2018.01887. eCollection 2018. Review.

5.

Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing.

Kesselheim AS, Woloshin S, Lu Z, Tessema FA, Ross KM, Schwartz LM.

JAMA Intern Med. 2019 May 1;179(5):707-709. doi: 10.1001/jamainternmed.2018.8121. No abstract available.

PMID:
30667474
6.

Visual Representations of Risk Enhance Long-Term Retention of Risk Information: A Randomized Trial.

Arrick BA, Bloch KJ, Colello LS, Woloshin S, Schwartz LM.

Med Decis Making. 2019 Feb;39(2):100-107. doi: 10.1177/0272989X18819493. Epub 2019 Jan 11.

PMID:
30632890
7.

Medical Marketing in the United States, 1997-2016.

Schwartz LM, Woloshin S.

JAMA. 2019 Jan 1;321(1):80-96. doi: 10.1001/jama.2018.19320.

PMID:
30620375
8.

Trends in Testosterone Prescribing for Age-related Hypogonadism in Men With and Without Heart Disease.

Morden NE, Woloshin S, Brooks CG, Schwartz LM.

JAMA Intern Med. 2019 Mar 1;179(3):446-448. doi: 10.1001/jamainternmed.2018.6505. No abstract available.

9.

Timeliness of Postmarket Studies for New Pharmaceuticals Approved Between 2009 and 2012: a Cross-Sectional Analysis.

Wallach JD, Egilman AC, Ross JS, Woloshin S, Schwartz LM.

J Gen Intern Med. 2019 Apr;34(4):492-495. doi: 10.1007/s11606-018-4779-x. No abstract available.

PMID:
30543020
10.

Internal Medicine Physicians' Financial Relationships with Industry: An Updated National Estimate.

Kesselheim AS, Woloshin S, Lu Z, Tessema FA, Ross KM, Schwartz LM.

J Gen Intern Med. 2019 Feb;34(2):195-197. doi: 10.1007/s11606-018-4688-z. No abstract available.

PMID:
30291605
11.

Focusing on overdiagnosis as a driver of too much medicine.

Brodersen J, Kramer BS, Macdonald H, Schwartz LM, Woloshin S.

BMJ. 2018 Aug 17;362:k3494. doi: 10.1136/bmj.k3494. No abstract available.

PMID:
30120097
12.

How Do Women View Risk-Based Mammography Screening? A Qualitative Study.

He X, Schifferdecker KE, Ozanne EM, Tosteson ANA, Woloshin S, Schwartz LM.

J Gen Intern Med. 2018 Nov;33(11):1905-1912. doi: 10.1007/s11606-018-4601-9. Epub 2018 Jul 31.

13.

Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis.

Wallach JD, Egilman AC, Dhruva SS, McCarthy ME, Miller JE, Woloshin S, Schwartz LM, Ross JS.

BMJ. 2018 May 24;361:k2031. doi: 10.1136/bmj.k2031.

14.

Overcoming overuse: the way forward is not standing still-an essay by Steven Woloshin and Lisa M Schwartz.

Woloshin S, Schwartz LM.

BMJ. 2018 May 22;361:k2035. doi: 10.1136/bmj.k2035. No abstract available.

PMID:
29789307
15.

Psychotropic medications for highly vulnerable children.

McLaren JL, Barnett ER, Concepcion Zayas MT, Lichtenstein J, Acquilano SC, Schwartz LM, Woloshin S, Drake RE.

Expert Opin Pharmacother. 2018 Apr;19(6):547-560. doi: 10.1080/14656566.2018.1445720. Epub 2018 Mar 29. Review.

PMID:
29596008
16.

Overdiagnosis: what it is and what it isn't.

Brodersen J, Schwartz LM, Heneghan C, O'Sullivan JW, Aronson JK, Woloshin S.

BMJ Evid Based Med. 2018 Feb;23(1):1-3. doi: 10.1136/ebmed-2017-110886. No abstract available.

PMID:
29367314
17.

Characteristics of Interim Publications of Randomized Clinical Trials and Comparison With Final Publications.

Woloshin S, Schwartz LM, Bagley PJ, Blunt HB, White B.

JAMA. 2018 Jan 23;319(4):404-406. doi: 10.1001/jama.2017.20653. No abstract available.

18.

Type 2 diabetes impairs the ability of skeletal muscle pericytes to augment postischemic neovascularization in db/db mice.

Hayes KL, Messina LM, Schwartz LM, Yan J, Burnside AS, Witkowski S.

Am J Physiol Cell Physiol. 2018 May 1;314(5):C534-C544. doi: 10.1152/ajpcell.00158.2017. Epub 2018 Jan 10.

19.

A Clear-eyed View of Restasis and Chronic Dry Eye Disease.

Schwartz LM, Woloshin S.

JAMA Intern Med. 2018 Feb 1;178(2):181-182. doi: 10.1001/jamainternmed.2017.7904. Review. No abstract available.

PMID:
29297040
20.

A Heparin Binding Motif Rich in Arginine and Lysine is the Functional Domain of YKL-40.

Ngernyuang N, Yan W, Schwartz LM, Oh D, Liu YB, Chen H, Shao R.

Neoplasia. 2018 Feb;20(2):182-192. doi: 10.1016/j.neo.2017.11.011. Epub 2017 Dec 20.

Supplemental Content

Loading ...
Support Center